Both in Pharmaceuticals
ANI Pharmaceuticals vs uniQure
Over the past year ANIP returned −20.7% and QURE returned −58.6%; their daily moves had a correlation of -0.10.
ANIP −20.7% QURE −58.6%Growth of $1, one year, split-adjusted
| Metric | ANIP | QURE |
|---|---|---|
| Price | $72.65 | $24.16 |
| Market cap | $1.67B | $1.68B |
| Today | +0.04% | −1.43% |
| 1 month | −0.8% | −50.4% |
| 6 months | −5.5% | +47.8% |
| Year to date | −8.0% | +1.0% |
| 1 year | −21.0% | −59.3% |
| Revenue growth (YoY) | +25.9% | +11.0% |
| Gross margin | 62.4% | 94.0% |
| Net margin | 8.6% | −1387.8% |
| P/E (TTM) | 16.8× | — |
| Price / sales | 1.7× | 89.8× |
| Net cash | -$234.7M | $760.2M |
| Dividend yield | — | — |
| Volatility (60d) | 30.0% | 107.3% |
| Short % of float | 13.0% | 15.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).